NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Not Allowed)
About
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Not Allowed) is a federal funding opportunity from National Institutes of Health. This forecasted grant opportunity (FOR-OD-26-003) is available nationwide for eligible applicants.
The NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Not Allowed) is a federal funding opportunity designed to support small businesses and research institutions collaborating to develop innovative technologies with potential commercial applications. This grant program is specifically structured to facilitate the transfer of research discoveries from academic institutions to small business entities, enabling entrepreneurs to transform cutting-edge scientific findings into viable products and services. The program emphasizes technology development and commercialization potential while explicitly excluding clinical trial activities from funded projects. Small businesses partnering with research institutions can leverage this funding to conduct feasibility studies, proof-of-concept work, and prototype development in various scientific and technological fields. This grant is ideal for innovative entrepreneurs seeking to bridge the gap between basic research and market-ready solutions, fostering collaboration between the scientific community and private sector innovation. The program encourages businesses to develop technologies across multiple NIH mission areas, supporting the commercialization of federally-funded research while maintaining rigorous scientific standards and peer review processes.
Grant Details
Funding Range
Varies by phase and NIH institute
Grant Type
Federal
Application Cycle
Annual or per FOA announcement cycle
Best For
Small businesses partnering with research institutions to commercialize innovative technologies
Frequently Asked Questions
Who is eligible for NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Not Allowed)?
Generally, this grant is available to small businesses that partner with research institutions such as universities, colleges, and federally-funded research centers. The small business must be the lead applicant and collaborate with an eligible research partner. For complete eligibility requirements, including business size criteria and specific partnership requirements, visit the official NIH STTR program website at grants.nih.gov.
How much funding does NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Not Allowed) provide?
Funding amounts vary by grant phase and specific NIH institute or center offering the opportunity. The STTR program typically operates in two phases: Phase I for feasibility studies and Phase II for further development. Specific funding levels for this forecasted opportunity (FOR-OD-26-003) should be verified on the official NIH grants portal.
How do I apply for NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Not Allowed)?
Applications are submitted through the NIH electronic submission system (eRA Commons). The process typically involves developing a research proposal with your research institution partner, completing required forms, and submitting through the official NIH grants portal. For detailed instructions, deadlines, and application requirements specific to this forecasted opportunity (FOR-OD-26-003), visit grants.nih.gov and consult the official Funding Opportunity Announcement (FOA).
What can NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Not Allowed) funding be used for?
Funding supports research and development activities aimed at demonstrating the scientific feasibility and commercial potential of innovative technologies. This includes feasibility studies, prototype development, proof-of-concept work, and preliminary commercialization planning. Notably, this funding cannot be used for clinical trials or human subject research involving clinical interventions. Contact your NIH program officer or visit grants.nih.gov for comprehensive guidance on allowable uses.
Last updated: March 1, 2026